Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform

Randox Drug Residues have released their newly improved Antimicrobial Array I. This comprehensive multiplex testing platform allows for the simultaneous detection of 15 of the most commonly abused sulphonamides in food production and agricultural industries.

Excellent limits of detection and simple sample preparations combine to make this product an impressive multi-analyte testing platform. Limits of detection for milk range from 0.5-2.5ppb which surpass any tolerance or maximum residue limits in place from regulatory bodies. Sample preparations are also available for honey, tissue, urine and feed, resulting in valuable time savings. Utilising the revolutionary Biochip Array Technology developed by Randox, high quality and reliable results are guaranteed. Investigator01

This new testing platform includes the following compounds: Sulphamerazine, Sulphadoxine, Sulphapyridine, Sulphamethoxypyridazine, Sulphachlorpyridazine, Sulphathiazole, Sulphisoxazole, Sulphadimethoxine, Sulphaquinoxaline, Sulphamethazine, Sulphadiazine, Sulphamethizole, Sulphamethoxazole, Sulphamonomethoxine and Trimethoprim. Testing all of these compounds simultaneously offers a more complete and reliable detection method.

The Antimicrobial Array I is used in conjunction with the patented Evidence Investigator system which allows for cost effective high throughput screening for a range of drug residues. The Evidence Investigator is a semi-automated biochip analyser

For further information please refer to the Randox Drug Residues website: https://www.randox.com/ or email: [email protected]

 

About Randox Drug Residues

Randox Drug Residues is dedicated to the development and manufacture of high quality drug residue testing solutions. We use in house developed antibodies and conjugates for a wide range of our screening products including the patented Biochip Array Technology – a proven multiplexing platform. We provide a range of excellent tools for screening for antimicrobials, growth promoting hormones and drugs of abuse in animals and foodstuffs. We offer excellent limit of detections and simple sample preparations. Our portfolio includes 25 ELISA’s and 5 multiplex screening platforms. All products are manufactured at our state-of-the-art ISO 13485 accredited manufacturing plant in the UK.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Randox. (2022, December 23). Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform. News-Medical. Retrieved on February 01, 2023 from https://www.news-medical.net/news/20110623/Randox-Drug-Residues-release-newly-improved-Multi-Sulphonamide-Testing-Platform.aspx.

  • MLA

    Randox. "Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform". News-Medical. 01 February 2023. <https://www.news-medical.net/news/20110623/Randox-Drug-Residues-release-newly-improved-Multi-Sulphonamide-Testing-Platform.aspx>.

  • Chicago

    Randox. "Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform". News-Medical. https://www.news-medical.net/news/20110623/Randox-Drug-Residues-release-newly-improved-Multi-Sulphonamide-Testing-Platform.aspx. (accessed February 01, 2023).

  • Harvard

    Randox. 2022. Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform. News-Medical, viewed 01 February 2023, https://www.news-medical.net/news/20110623/Randox-Drug-Residues-release-newly-improved-Multi-Sulphonamide-Testing-Platform.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Randox partners with government to develop new coronavirus testing program